<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: BIOTECH: Evaluating Interventions With No Close Substitutes</title>
	<atom:link href="http://healthaffairs.org/blog/2006/10/24/biotech-evaluating-interventions-with-no-close-substitutes/feed/" rel="self" type="application/rss+xml" />
	<link>http://healthaffairs.org/blog/2006/10/24/biotech-evaluating-interventions-with-no-close-substitutes/</link>
	<description>The Policy Journal of the Health Sphere</description>
	<lastBuildDate>Fri, 20 Nov 2009 20:04:42 -0500</lastBuildDate>
	
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Envisioning 2.0 &#187; Blog Archive &#187; A Boost For Generics Under Democrats?</title>
		<link>http://healthaffairs.org/blog/2006/10/24/biotech-evaluating-interventions-with-no-close-substitutes/comment-page-1/#comment-197</link>
		<dc:creator>Envisioning 2.0 &#187; Blog Archive &#187; A Boost For Generics Under Democrats?</dc:creator>
		<pubDate>Wed, 22 Nov 2006 16:22:36 +0000</pubDate>
		<guid isPermaLink="false">http://healthaffairs.org/blog/2006/10/24/biotech-evaluating-interventions-with-no-close-substitutes/#comment-197</guid>
		<description>[...] - Drug Channels: The Attack On Generic Profits In Drug Channels  - The Health Affairs Blog: Evaluating Interventions With No Close Substitutes [...]</description>
		<content:encoded><![CDATA[<p>[...] &#8211; Drug Channels: The Attack On Generic Profits In Drug Channels  &#8211; The Health Affairs Blog: Evaluating Interventions With No Close Substitutes [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
